Cost-effectiveness of screening patients for hepatitis C

American Journal of Medicine

Volumn 107, Issue 6 SUPPL. 2, 1999, Pages 36-40

  Gordon, Fredric D ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; DRUG ABUSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; MASS SCREENING; PATIENT EDUCATION; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; SEXUAL TRANSMISSION; SOCIAL STATUS;

EID: 0033375483     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00379-4     Document Type: Conference Paper

References (10)

1. Kim W.R., Poterucha J.J., Hermans J.E., et al. Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. Ann Intern Med. 127:1997;866-874.
2. Bennett W.G., Inoue Y., Beck J.R., et al. Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med. 127:1997;855-865.
3. Dusheiko G.M., Roberts J.A. Treatment of chronic type B and hepatitis with interferon alfa an economic appraisal . Hepatology. 22:1995;1863-1873.
4. Kaur S., Rybicki L., Bacon B.R., et al. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group . Hepatology. 24:1996;979-986.
5. Lapane K.L., Jakiche A.F., Sugano D., et al. Hepatitis C infection risk analysis who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program . Am J Gastroenterol. 93:1998;591-596.
6. Flamm S.L., Parker R.A., Chopra S. Risk factors associated with chronic hepatitis C virus infection limited frequency of an unidentified source of transmission . Am J Gastroenterol. 93:1998;597-600.
7. National Institutes of Health Consensus Development Conference Panel Statement: management of hepatitis C. Hepatology 1997;26(3 suppl 1):2S-10S.
8. Dhumeaux D., Doffoel M., Galmiche J.P. A French consensus conference on hepatitis C screening and treatment . J Hepatol. 27:1997;941-944.
9. American Academy of Pediatrics. Hepatitis C Virus Infection (RE9733). 1998:htt://www.aap.org/policy/re9733.html.
10. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998;47(RR-19):1-39.